147 related articles for article (PubMed ID: 3198133)
1. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).
Masucci G; Lindemalm C; Frödin JE; Hagström B; Mellstedt H
Hybridoma; 1988 Oct; 7(5):429-40. PubMed ID: 3198133
[TBL] [Abstract][Full Text] [Related]
2. Lymphokine activated killer (LAK) cells in antibody dependent cellular cytotoxicity (ADCC) using MAb 17-1A: a combination of potential usefulness in tumor therapy.
Masucci G; Wersäll P; Nielsen J; Nielsen HK; Wigzell H; Mellstedt H
Hybridoma; 1989 Oct; 8(5):507-16. PubMed ID: 2807310
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor.
Ragnhammar P; Masucci G; Frödin JE; Hjelm AL; Mellstedt H
Cancer Immunol Immunother; 1992; 35(3):158-64. PubMed ID: 1638551
[TBL] [Abstract][Full Text] [Related]
4. Growth suppression of colorectal cancer by plant-derived multiple mAb CO17-1A × BR55 via inhibition of ERK1/2 phosphorylation.
Kwak DH; Moussavou G; Lee JH; Heo SY; Ko K; Hwang KA; Jekal SJ; Choo YK
Int J Mol Sci; 2014 Nov; 15(11):21105-19. PubMed ID: 25405740
[TBL] [Abstract][Full Text] [Related]
5. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
[TBL] [Abstract][Full Text] [Related]
7. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG
Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of autologous blood mononuclear cells used for auto-infusion together with monoclonal antibodies in tumor treatment.
Frödin JE; Pihlstedt P; Lefvert AK; Mellstedt H
Hybridoma; 1987 Dec; 6(6):555-64. PubMed ID: 3325401
[TBL] [Abstract][Full Text] [Related]
9. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
[TBL] [Abstract][Full Text] [Related]
10. Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells.
Primus FJ; Pendurthi TK; Hutzell P; Kashmiri S; Slavin DC; Callahan R; Schlom J
Cancer Immunol Immunother; 1990; 31(6):349-57. PubMed ID: 2386980
[TBL] [Abstract][Full Text] [Related]
11. Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement.
Rosales C; Jeglum KA; Obrocka M; Steplewski Z
Cell Immunol; 1988 Sep; 115(2):420-8. PubMed ID: 3409330
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16.
Reali E; Guiliani AL; Spisani S; Moretti S; Gavioli R; Masucci G; Gambari R; Traniello S
Clin Immunol Immunopathol; 1994 Apr; 71(1):105-12. PubMed ID: 8137553
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.
Wersäll P; Masucci G; Mellstedt H
Cancer Immunol Immunother; 1991; 33(1):45-9. PubMed ID: 2021957
[TBL] [Abstract][Full Text] [Related]
14. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
15. Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies.
Lubeck MD; Kimoto Y; Steplewski Z; Koprowski H
Cell Immunol; 1988 Jan; 111(1):107-17. PubMed ID: 3338092
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines.
Flieger D; Spengler U; Beier I; Kleinschmidt R; Hoff A; Varvenne M; Sauerbruch T; Schmidt-Wolf I
Hybridoma; 1999 Feb; 18(1):63-8. PubMed ID: 10211790
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.
Masucci G; Wersäll P; Ragnhammar P; Mellstedt H
Cancer Immunol Immunother; 1989; 29(4):288-92. PubMed ID: 2665935
[TBL] [Abstract][Full Text] [Related]
18. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
19. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
Velders MP; Litvinov SV; Warnaar SO; Gorter A; Fleuren GJ; Zurawski VR; Coney LR
Cancer Res; 1994 Apr; 54(7):1753-9. PubMed ID: 8137290
[TBL] [Abstract][Full Text] [Related]
20. Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2.
Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf I
Cytokine; 2000 Jun; 12(6):756-61. PubMed ID: 10843759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
